The marketplace connecting CE Professionals, Event Hosts, Business & Industry, and Speakers.

For Professionals

Browse Events
CE Professionals
Speakers & Authors

For Organizations

Exhibitors & Sponsors
Event Hosts

Company

About
Log In
Create Account
FAQ
Terms of Use
Privacy Policy
Sub-processors
Contact Us

The marketplace connecting CE Professionals, Event Hosts, Business & Industry, and Speakers.

For Professionals

Browse Events
CE Professionals
Speakers & Authors

For Organizations

Exhibitors & Sponsors
Event Hosts

Company

About
Log In
Create Account
FAQ
Terms of Use
Privacy Policy
Sub-processors
Contact Us

Terms Privacy

The Emerging Ro… | Virtual Event | 0.50 hours CE Credits | networkED.global

Virtual0.5 CE Credits

The Emerging Role of Antibody-Drug Conjugates in Perioperative Treatment of MIBC

Hosted by Medscape, LLC

May 6, 2026 – Jun 3, 2026 Online / Virtual

About This Event

This live course examines the scientific rationale and emerging clinical evidence for incorporating antibody-drug conjugates (ADCs) into the multidisciplinary perioperative management of patients with muscle-invasive bladder cancer (MIBC). Participants will evaluate current evidence and treatment strategies for this patient population.

Registration & Fees

Continuing Education

0.5 CE Credits

Accredited by: ACCME

AMA PRA Category 1 Credit, Nursing, Pharmacy, and IPCE credits available

Visit Event Website Register Now

You'll be redirected to the organizer's registration site

Key Dates

Event Start DateMay 6, 2026 – Jun 3, 2026

Attendee Registration Opens*

Early Bird Registration Deadline*

*These dates are not yet available from the host.